Wednesday, 16 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14398
Articles
Company
Drug
Abbisko Therapeutics Doses First Patient in ABSK061 Phase I Study for Solid Tumors
March 3, 2025
Company
Drug
Ascletis Pharma Doses First Patient in ASC22 HIV Study with Chidamide
March 3, 2025
Company
Deals
Fosun Pharmaceutical and ReNeuron Renew CTX Cell Therapy Deal for China
March 3, 2025
Company
Eurofins DiscoverX Opens Shanghai Office to Expand Asia-Pacific Operations
March 3, 2025
Company
Deals
Solasia Pharma Reduces China Operations, Transfers Drug Rights to Lee’s
March 3, 2025
Policy / Regulatory
NMPA Releases Plans to Support HK and Macau Drug, Device Production in Mainland Cities
March 3, 2025
Company
Drug
Bio-Thera Solutions’ BAT8010 Receives NMPA Approval for Solid Tumor Clinical Trials
March 3, 2025
Company
Drug
Kelun Pharma’s SKB264 ADC Receives Breakthrough Therapy Designation for TNBC
March 3, 2025
Company
R&D
Burning Rock Biotech Launches PREVENT Study for Early Cancer Detection
March 3, 2025
Company
Deals
Harbour BioMed’s Partner NK Celltech Raises RMB 100M in Series A Financing
March 3, 2025
Policy / Regulatory
NMPA Releases 55th Batch of Reference Drugs for Generic Evaluation
March 3, 2025
Company
Drug
BeiGene’s Tislelizumab Shows Survival Benefit in Esophageal Cancer Study
March 3, 2025
1
2
…
1,182
1,183
1,184
1,185
1,186
…
1,199
1,200
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?